Tuesday, May 10th, 2016

WiseGuyReports.com adds “Pulmonary Fibrosis - Pipeline Review, H1 2016” new report to its research database. The report Spread across 380 pages with tables and figures.

The report “Pulmonary Fibrosis - Pipeline Review, H1 2016” provides comprehensive information on the therapeutics under development for Pulmonary Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Fibrosis and features dormant and discontinued projects.

Complete Report Details Available at https://www.wiseguyreports.com/reports/pulmonary-fibrosis-pipeline-review-h1-2016-fibrosis-pipeline-review-h1-2016 .

Companies mentioned in this report are:

AdAlta Pty Ltd., Advinus Therapeutics Ltd., Aeolus Pharmaceuticals, Inc., Afferent Pharmaceuticals, Inc., AnaMar AB, Angion Biomedica Corp., Antitope Limited, aTyr Pharma, Inc., Biogen, Inc., Bioneer Corporation, BiOrion Technologies B.V., Bristol-Myers Squibb Company, Carolus Therapeutics, Inc., Celgene Corporation, Chong Kun Dang Pharmaceutical Corp., Clanotech AB, Compugen Ltd., Cynata Therapeutics Limited, Diffusion Pharmaceuticals Inc., Digna Biotech, S.L., Elsalys Biotech SAS, F. Hoffmann-La Roche Ltd., FibroGen, Inc., Galapagos NV, Galectin Therapeutics, Inc., GenKyoTex S.A., GlaxoSmithKline Plc, Global Blood Therapeutics, Inc., HanAll Biopharma Co., Ltd., HEC Pharm Co., Ltd., Histocell S.L., Hydra Biosciences, Inc., iBio, Inc., Inventiva, Isarna Therapeutics GmbH, Kadmon Corporation, LLC, Kasiak Research Private Limited, KineMed, Inc., Kyorin Pharmaceutical Co., Ltd., Lpath, Inc., miRagen Therapeutics, Inc., Moerae Matrix, Inc., MorphoSys AG, NicOx S.A., Novartis AG, Pacific Therapeutics Ltd., Pharmaxis Limited, Pharmicell Co., Ltd., Pluristem Therapeutics Inc., Progenra, Inc., Promedior, Inc., ProMetic Life Sciences Inc., Pulmatrix, Inc., RedHill Biopharma Ltd., Respira Therapeutics, Inc., Rhizen Pharmaceuticals S.A., Ribomic Inc., Saje Pharma, LLC, Sanofi, SciFluor Life Sciences, LLC, Symic Biomedical, Inc., TaiwanJ Pharmaceuticals Co., Ltd., Teva Pharmaceutical Industries Limited, Therabron Therapeutics, Inc., Vericel Corporation, Yuhan Corporation.

Inquire more about this report at https://www.wiseguyreports.com/enquiry/pulmonary-fibrosis-pipeline-review-h1-2016-fibrosis-pipeline-review-h1-2016 .


- The report provides a snapshot of the global therapeutic landscape of Pulmonary Fibrosis 
- The report reviews pipeline therapeutics for Pulmonary Fibrosis by companies and universities/research institutes based on information derived from company and industry-specific sources 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved Pulmonary Fibrosis therapeutics and enlists all their major and minor projects 
- The report assesses Pulmonary Fibrosis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report summarizes all the dormant and discontinued pipeline projects 
- The report reviews latest news related to pipeline therapeutics for Pulmonary Fibrosis

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Pulmonary Fibrosis 
- Identify potential new clients or partners in the target demographic 
- Develop strategic initiatives by understanding the focus areas of leading companies 
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics 
- Devise corrective measures for pipeline projects by understanding Pulmonary Fibrosis pipeline depth and focus of Indication therapeutics 
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope 
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Get a sample copy at https://www.wiseguyreports.com/sample-request/pulmonary-fibrosis-pipeline-review-h1-2016-fibrosis-pipeline-review-h1-2016 .

Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349
W: www.wiseguyreports.com/


Pulmonary Fibrosis Hepatitis Therapeutics, Pulmonary Fibrosis Hepatitis Therapeutics Market, Pulmonary Fibrosis Hepatitis Therapeutics Market Trends, Pulmonary Fibrosis Hepatitis Therapeutics Industry Trends, Pulmonary Fibrosis Hepatitis




More Formats

View QR Code